Incorporating some potential obstacles arising from recent Chinese developments
15/09/23 -"Despite Philips gaining confidence, thanks to promising testing results for respiratory devices, improving operations and a big new investor coming on board, our target price resets lower due to ..."
Pages
67
Language
English
Published on
15/09/23
You may also be interested by these reports :
04/09/26
Bastide ended FY25/26 above its revenue target, with Q4 organic growth recovering as the VPH headwind faded, confirming the one-off nature of the ...
01/09/26
We have resumed our coverage of the Tecan Group, updating the company’s accounts and our forecasts. The share price has gained strong momentum since ...
01/09/26
Dräger’s final Q2 26 results confirmed margin acceleration across both divisions, alongside a sharp improvement in FCF and net debt. The key ...
27/08/26
Elekta’s Q1 sales fell short of expectations, although profitability surpassed forecasts. The top line declined due to underperformance in Solutions, ...